Clemastine fumarate, sold under the brand name Tavist, was pulled from the market not because of safety concerns but because the manufacturer chose to stop making it. The FDA confirmed in an October 2024 determination that Tavist (clemastine fumarate) tablet, 2.68 mg, “was not withdrawn for reasons of safety or effectiveness.” The drug simply became commercially unattractive, and production stopped.
Why the Brand Name Disappeared
Tavist is listed in the FDA’s “Discontinued Drug Product List” in the Orange Book, the federal database that tracks approved medications and their marketing status. That list specifically covers drugs “discontinued from marketing for reasons other than safety or effectiveness.” In practical terms, this means the original manufacturer made a business decision to stop producing Tavist. Older antihistamines like clemastine lost significant market share once newer, non-drowsy options like loratadine (Claritin) and cetirizine (Zyrtec) became widely available over the counter. When a drug generates less revenue than it costs to manufacture and distribute, companies quietly let it go.
For years after the brand-name version disappeared, over-the-counter clemastine fumarate in lower doses (1.34 mg) could still be found on pharmacy shelves. But those products also became increasingly scarce as manufacturers made similar calculations about profitability. A drug that relatively few people were buying, in a market dominated by newer alternatives, simply wasn’t worth keeping in production for most companies.
A Prescription Version Recently Returned
There is good news if you’ve been searching for clemastine. A prescription-strength generic (2.68 mg tablets) received a new marketing start date of November 20, 2024, according to the FDA’s DailyMed database. This version is labeled as a prescription-only product approved through an abbreviated new drug application, meaning a generic manufacturer has begun offering it again.
This prescription version is indicated for allergic rhinitis symptoms (sneezing, runny nose, itchy and watery eyes) and for mild allergic skin reactions like hives. Because it’s prescription-only at this strength, you’d need to ask your doctor or allergist to write a script for it, and your pharmacy would need to order it from their distributor.
The FDA Ruling That Cleared the Way
The reason a generic manufacturer can now market clemastine again ties directly to the FDA’s October 2024 determination. When a brand-name drug gets listed as “discontinued,” generic companies face a regulatory question: was it pulled for safety reasons? If so, they can’t make it either. Someone filed a citizen petition asking the FDA to formally clarify that Tavist wasn’t removed for safety or effectiveness concerns. After reviewing its records, the FDA agreed. That determination essentially reopened the door for generic manufacturers to produce and sell clemastine fumarate without the cloud of a potential safety withdrawal hanging over the product.
Why Clemastine Attracted New Interest
Clemastine’s disappearance became more frustrating in recent years because researchers discovered it may do something no other approved drug can do: repair damaged myelin, the protective coating around nerve fibers that gets destroyed in multiple sclerosis. A clinical trial called ReBUILD tested clemastine in MS patients and found evidence of remyelination, generating significant excitement in the neurology community. This research created a new population of people actively looking for a drug that had largely vanished from pharmacy shelves.
The MS research didn’t directly cause the shortage, since clemastine was already hard to find before those trials gained attention. But it did amplify awareness of the gap. Patients and neurologists who wanted to try clemastine off-label for MS found themselves unable to get a drug that had been a routine allergy medication for decades. That growing demand likely contributed to the push for the FDA’s formal determination and the eventual return of a generic version.
How to Find It Now
If you’re looking for clemastine fumarate today, your best option is asking for the prescription-strength 2.68 mg tablet through your doctor. Because the generic only recently re-entered the market, not every pharmacy will have it in stock immediately. Your pharmacist can check availability through their wholesale distributors and order it if it’s not on the shelf.
Over-the-counter clemastine at the lower 1.34 mg dose may still appear sporadically at some pharmacies or online retailers, but supply remains inconsistent. If you find it on a store shelf, check the expiration date carefully, as remaining stock may be old inventory. For reliable, ongoing access, the prescription route is currently the more dependable path.